More on MREO
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.38 |
|
|||
| Open | $0.38 | ||||
| 52 Wk High | $0.01 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $0.39 | ||||
| Day Low | $0.34 | ||||
| P/E | N/A | ||||
| EPS | $-0.02 | ||||
| Volume | 1,192,223 | ||||
- Mereo BipPharma Group (MREO) Reiterated at Overweight by Cantor Fitzgerald
- Form 8-K Mereo BioPharma Group For: Aug 18
- JPMorgan Downgrades Mereo BipPharma Group (MREO) to Underweight
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: EcoR1 Capital, LLC
- Mereo BioPharma (MREO) Reports In-Line Q2 EPS
- Form 10-Q Mereo BioPharma Group For: Jun 30
- Form 8-K Mereo BioPharma Group For: Aug 11
- Mereo BioPharma posts Q2 loss, signs alvelestat deal with Sentynl
- Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
- Form 8-K Mereo BioPharma Group For: Aug 11
Entities mentioned with MREO
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Show More...
